Position in PFE
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$520,416
-$86,448 QoQ
Shares Held
21,612
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.17%
of 13F equity value
Holder Rank
#1,730
of 2,821 holders
Holding Since
Sep 2022
16 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Alta Advisers Ltd holds $11,367,856 across 8 Drug Manufacturers - General names. PFE ranks #7 (4.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
3,079 | $3,693,045 | |
| 2 | JNJ |
Johnson & Johnson
|
9,368 | $2,379,190 | |
| 3 | ABBV |
AbbVie Inc.
|
6,765 | $1,702,344 | |
| 4 | MRK |
Merck & Co., Inc.
|
9,584 | $1,231,544 | |
| 5 | AMGN |
Amgen Inc
|
2,110 | $764,073 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
4,992 | $630,689 | |
| 7 | PFE |
Pfizer Inc
This page
|
21,612 | $520,416 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
7,750 | $446,555 |
All Filings in PFE
Export CSV
16 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $520,416 | 21,612 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $606,864 | 21,612 | Shares | Defined | 2026-05-07 | |
| 2025-12-31 | $538,138 | 21,612 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $790,185 | 31,012 | Shares | Defined | 2025-10-31 | |
| 2025-06-30 | $773,546 | 31,912 | Shares | Defined | 2025-07-25 | |
| 2025-03-31 | $808,650 | 31,912 | Shares | Defined | 2025-04-25 | |
| 2024-12-31 | $499,082 | 18,812 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $457,252 | 15,800 | Shares | Defined | 2024-11-08 | |
| 2024-06-30 | $442,084 | 15,800 | Shares | Defined | 2024-08-08 | |
| 2024-03-31 | $407,925 | 14,700 | Shares | Defined | 2024-04-24 | |
| 2023-12-31 | $423,213 | 14,700 | Shares | Defined | 2024-02-12 | |
| 2023-09-30 | $487,599 | 14,700 | Shares | Defined | 2023-11-03 | |
| 2023-06-30 | $539,196 | 14,700 | Shares | Defined | 2023-07-25 | |
| 2023-03-31 | $599,760 | 14,700 | Shares | Defined | 2023-05-09 | |
| 2022-12-31 | $753,228 | 14,700 | Shares | Sole | 2023-01-27 | |
| 2022-09-30 | $643,272 | 14,700 | Shares | Sole | 2022-10-28 | |
| No filing history on record for this holder in this stock. | ||||||